| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/26/2007 | WO2007066018A3 Novel peptides and the biological use thereof |
| 07/26/2007 | WO2007065957A3 Methods for generating antigen-specific effector t cells |
| 07/26/2007 | WO2007062852A3 ANTI-Aβ GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIES |
| 07/26/2007 | WO2007058833A3 Dof (dna binding with one finger) sequences and methods of use |
| 07/26/2007 | WO2007056304A3 Mutated forms of ny-eso-1 produced in yeast and uses thereof |
| 07/26/2007 | WO2007054310A3 Pyroglue |
| 07/26/2007 | WO2007053637A3 A tumor susceptible rat with a mutation in apc gene |
| 07/26/2007 | WO2007048780A3 Nucleic acid molecules encoding phosphatidate cytidylyl-transferase-like polypeptides and methods of use |
| 07/26/2007 | WO2007048638A3 Botulinum neurotoxin a protein receptor and uses thereof |
| 07/26/2007 | WO2007048026A3 Cgrp peptide antagonists and conjugates |
| 07/26/2007 | WO2007042778A3 Monitoring cardiovascular disease by determining the expression of kir2ds2 and/or dap12 |
| 07/26/2007 | WO2007041487A3 Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family |
| 07/26/2007 | WO2007031222A3 Identification of tumor-associated antigens for diagnosis and therapy |
| 07/26/2007 | WO2007030008A3 Ruvx holliday junction resolvase genes and methods of use |
| 07/26/2007 | WO2007026310A3 Improved stress tolerance in plants |
| 07/26/2007 | WO2007026078A3 T cd4+ epitopes of mage-a antigens restricted to hla-dp4 and the use thereof |
| 07/26/2007 | WO2007022369A3 Chemically modified short interfering nucleic acid molecules that mediate rna interference |
| 07/26/2007 | WO2007022287A3 Modified vegf and pdgf with improved angiogenic properties |
| 07/26/2007 | WO2007021494A3 Albumin fusion proteins |
| 07/26/2007 | WO2007018442A3 Expression of an active carrier for xylose in genetically modified saccharomyces cerevisiae |
| 07/26/2007 | WO2007010133A3 Polypeptides having an activity in the mtbe degradation path and uses thereof |
| 07/26/2007 | WO2007008604A3 Single nucleotide polymorphisms associated with dose-dependent edema and methods of use thereof |
| 07/26/2007 | WO2007002031A3 Dna polymerase blends and mutant dna polymerases |
| 07/26/2007 | WO2006138562A3 Epitope analogues |
| 07/26/2007 | WO2006113861A3 Mammalian expression systems |
| 07/26/2007 | WO2006110677A3 Gene inactivated mutants with altered protein production |
| 07/26/2007 | WO2006081249A9 Conjugates of biologically active proteins having a modified in vivo half-life |
| 07/26/2007 | WO2006062877A3 Protein subcellular localization assays using split fluorescent proteins |
| 07/26/2007 | WO2006057917A3 Hemipteran 5ht1 receptor |
| 07/26/2007 | WO2006055644A3 Synthesis and use of glycodendrimer reagents |
| 07/26/2007 | WO2005084158A3 Polypeptide transduction and fusogenic peptides |
| 07/26/2007 | WO2004090097A3 Polynucleotide encoding a novel human p2x7 splice variant, hbmyp2x7v |
| 07/26/2007 | WO2004003175A3 Process and materials for production of glucosamine and n-acetylglucosamine |
| 07/26/2007 | WO2003053220A3 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| 07/26/2007 | WO2003023010A3 Sensory neuron receptors |
| 07/26/2007 | WO2002038600A9 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 07/26/2007 | US20070174938 Corn root preferential promoters and uses thereof |
| 07/26/2007 | US20070174937 Plant having tolerance to environmental stress |
| 07/26/2007 | US20070174936 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 07/26/2007 | US20070174932 High amylose potato polysaccharide for use as renewable raw materials in food processing |
| 07/26/2007 | US20070174926 Sperm factor oscillogenin |
| 07/26/2007 | US20070174924 Transgenic mice containing TRP gene disruptions |
| 07/26/2007 | US20070174923 Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS) |
| 07/26/2007 | US20070174922 Nucleic acid encoding novel type-1 cytokine receptor glm-r |
| 07/26/2007 | US20070173636 Reacting a peptide acyl donor comprising a peptidic backbone made up of two or more amino acids with a peptide amine acceptor under reducing reaction conditions employing an excess of a reducing agent; |
| 07/26/2007 | US20070173466 Methods of treating inflammatory diseases associated with bone destruction |
| 07/26/2007 | US20070173458 Neo-tryptophan |
| 07/26/2007 | US20070173457 Tau-conotoxin peptides |
| 07/26/2007 | US20070173455 Peptide fragments and optionally excipients, used for prophylaxis of obesity and non-insulin dependent diabetes; antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP |
| 07/26/2007 | US20070173452 Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity |
| 07/26/2007 | US20070173451 Methods of using soluble heterodimeric cytokine receptor |
| 07/26/2007 | US20070173446 Administering porcine B-domainless factor VIII (OBI-1) to patient having factor VIII deficiency using recombinant B-domainless porcine fVIII, which has greater bioavailability compared to the natural porcine fVIII partially purified from porcine plasma, termed HYATE:C; hemophilia treatment |
| 07/26/2007 | US20070173445 Methods for treating viral infection using il-28 and il-29 |
| 07/26/2007 | US20070173443 polypeptides that induce apoptosis of cancer cells that contain mutant p53 or over-expressed wild-type p53 |
| 07/26/2007 | US20070173441 Inhibitors of n ethymalemide sensitive factor |
| 07/26/2007 | US20070173439 Administering formulation comprising polypeptide and muteins, fused proteins, muteins, functional derivatives and active fragments for treating autoimmune diseases, Type I diabetes, rheumatoid arthritis, graft rejections, inflammatory bowel disease, sepsis, multiple sclerosis, ischemic heart disease etc. |
| 07/26/2007 | US20070172947 expanding Treg cells ; for type 1 diabetes; autoimmune disease, graft versus host disease, genetically inherited hematopoietic disorder, rheumatoid arthritis and multiple sclerosis |
| 07/26/2007 | US20070172936 Purified active HCV NS2/3 protease |
| 07/26/2007 | US20070172930 process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereof |
| 07/26/2007 | US20070172928 Immunoglobulin chimeric monomer-dimer hybrids |
| 07/26/2007 | US20070172927 Immune complexes comprising proteins of human immunodeficiency virus type 2 (HIV-2), antibodies against proteins of HIV-2, methods and kits employing proteins of HIV-2, and immunogenic compositions comprising proteins of HIV-2 |
| 07/26/2007 | US20070172924 Increasing the stability of recombinant adult human apohemoglobin |
| 07/26/2007 | US20070172923 Homogeneous preparations of il-28 and il-29 |
| 07/26/2007 | US20070172922 Secretion, transcription and sporulation genes in Bacillus clausii |
| 07/26/2007 | US20070172921 Secretion, transcription and sporulation genes in Bacillus clausii |
| 07/26/2007 | US20070172919 WDR36 Gene Alterations and Glaucoma |
| 07/26/2007 | US20070172918 Non aggregating fluorescent proteins and methods for using the same |
| 07/26/2007 | US20070172917 Cytokine receptor zalpha11 |
| 07/26/2007 | US20070172915 Glycoprotein synthesis |
| 07/26/2007 | US20070172914 Protein concentrate and an aqueous stream containing water-soluble carbohydrates |
| 07/26/2007 | US20070172909 Non-ribosomal peptide synthetases and associated biosynthetic genes |
| 07/26/2007 | US20070172893 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172892 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 07/26/2007 | US20070172889 Human Zven polypeptides |
| 07/26/2007 | US20070172882 Identification of a family of secreted proteins in vascular endothelium |
| 07/26/2007 | US20070172881 Expression vector comprising fungal gene sequences for use as tool in identifying antifungal polypeptides for use in treatment and prevention of fungal infection |
| 07/26/2007 | US20070172880 Transient Receptor Potential Channels is an emerging class of Ca2+-permeable cation channel superfamily; for diagnosis, treatment, and/or prevention of various diseases |
| 07/26/2007 | US20070172850 Novel chromophores/fluorophores and methods for using the same |
| 07/26/2007 | US20070172848 Novel calpastatin (cast) alleles |
| 07/26/2007 | US20070172830 Antibodies to hhpen62 polypeptide |
| 07/26/2007 | US20070172517 Compositions capable of facilitation penetration across a biological barrier |
| 07/26/2007 | US20070172516 Increasing of the resorption of substances via skin and mucous membranes |
| 07/26/2007 | US20070172501 Method of immunizing humans against salmonella typhi using a Vi-rEPA conjugate vaccine |
| 07/26/2007 | US20070172500 Anthrax antitoxins |
| 07/26/2007 | US20070172498 Polypeptides for inducing a protective immune response against staphyloococcus aureus |
| 07/26/2007 | US20070172497 BoNT/A PEPTIDES AND METHODS OF PREDICTING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY |
| 07/26/2007 | US20070172496 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
| 07/26/2007 | US20070172495 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 07/26/2007 | US20070172494 Cold-adapted equine influenza viruses |
| 07/26/2007 | US20070172489 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza |
| 07/26/2007 | US20070172486 used to treat tumor (osteosarcoma or Ewing's sarcoma); restenosis |
| 07/26/2007 | US20070172484 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 07/26/2007 | US20070172480 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172478 Methods of treating skin disorders |
| 07/26/2007 | US20070172471 Method for identifying an anti- streptococcal agent and its use for treating streptococcal infections |
| 07/26/2007 | US20070172460 Random peptide library displayed on aav vectors |
| 07/26/2007 | US20070172459 modified interferons for use in the treatment and prevention of viral infections, cell proliferative and autoimmune disorders |
| 07/26/2007 | US20070172458 IL-6/IL-6R fusion protein |
| 07/26/2007 | US20070172457 Interleukins-21 and 22 |
| 07/26/2007 | US20070172456 IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides |